BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20975234)

  • 21. Compound heterozygosity for mutations Asp611-->Tyr in KCNQ1 and Asp609-->Gly in KCNH2 associated with severe long QT syndrome.
    Yamaguchi M; Shimizu M; Ino H; Terai H; Hayashi K; Kaneda T; Mabuchi H; Sumita R; Oshima T; Hoshi N; Higashida H
    Clin Sci (Lond); 2005 Feb; 108(2):143-50. PubMed ID: 15500450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric Cohort With Long QT Syndrome - KCNH2 Mutation Carriers Present Late Onset But Severe Symptoms.
    Ozawa J; Ohno S; Hisamatsu T; Itoh H; Makiyama T; Suzuki H; Saitoh A; Horie M
    Circ J; 2016; 80(3):696-702. PubMed ID: 26823142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance.
    Barc J; Briec F; Schmitt S; Kyndt F; Le Cunff M; Baron E; Vieyres C; Sacher F; Redon R; Le Caignec C; Le Marec H; Probst V; Schott JJ
    J Am Coll Cardiol; 2011 Jan; 57(1):40-7. PubMed ID: 21185499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N- and C-terminal KCNE1 mutations cause distinct phenotypes of long QT syndrome.
    Ohno S; Zankov DP; Yoshida H; Tsuji K; Makiyama T; Itoh H; Akao M; Hancox JC; Kita T; Horie M
    Heart Rhythm; 2007 Mar; 4(3):332-40. PubMed ID: 17341399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations.
    Zhang X; Chen S; Zhang L; Liu M; Redfearn S; Bryant RM; Oberti C; Vincent GM; Wang QK
    BMC Med Genet; 2008 Sep; 9():87. PubMed ID: 18808722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of ion channel gene variants in patients with long QT syndrome.
    Ernesto C; Cruz FE; Lima FS; Coutinho JL; Silva R; Urményi TP; Carvalho AC; Rondinelli E
    Arq Bras Cardiol; 2011 Mar; 96(3):172-8. PubMed ID: 21308345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypokalemia-induced long QT syndrome with an underlying novel missense mutation in S4-S5 linker of KCNQ1.
    Kubota T; Shimizu W; Kamakura S; Horie M
    J Cardiovasc Electrophysiol; 2000 Sep; 11(9):1048-54. PubMed ID: 11021476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Digenic heterozygous mutations of KCNH2 and SCN5A induced young and early-onset long QT syndrome and sinoatrial node dysfunction.
    Yang Z; Ma Y; Huang J; Xian J; Huang Y; Wu L; Zhu W; Wang F; Chen L; Lin X; Lin Y
    Ann Noninvasive Electrocardiol; 2022 Jan; 27(1):e12889. PubMed ID: 34755423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overlapping LQT1 and LQT2 phenotype in a patient with long QT syndrome associated with loss-of-function variations in KCNQ1 and KCNH2.
    Cordeiro JM; Perez GJ; Schmitt N; Pfeiffer R; Nesterenko VV; Burashnikov E; Veltmann C; Borggrefe M; Wolpert C; Schimpf R; Antzelevitch C
    Can J Physiol Pharmacol; 2010 Dec; 88(12):1181-90. PubMed ID: 21164565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil.
    Aiba T; Shimizu W; Inagaki M; Noda T; Miyoshi S; Ding WG; Zankov DP; Toyoda F; Matsuura H; Horie M; Sunagawa K
    J Am Coll Cardiol; 2005 Jan; 45(2):300-7. PubMed ID: 15653031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A presumably benign human ether-a-go-go-related gene mutation (R176W) with a malignant primary manifestation of long QT syndrome.
    Donner BC; Marschall C; Schmidt KG
    Cardiol Young; 2012 Jun; 22(3):360-3. PubMed ID: 22067087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence.
    Berthet M; Denjoy I; Donger C; Demay L; Hammoude H; Klug D; Schulze-Bahr E; Richard P; Funke H; Schwartz K; Coumel P; Hainque B; Guicheney P
    Circulation; 1999 Mar; 99(11):1464-70. PubMed ID: 10086971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics of patients with congenital long QT syndrome and bigenic mutations.
    Jimmy JJ; Chen CY; Yeh HM; Chiu WY; Yu CC; Liu YB; Tsai CT; Lo LW; Yeh SF; Lai LP
    Chin Med J (Engl); 2014; 127(8):1482-6. PubMed ID: 24762593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes.
    Volders PG; Sipido KR; Vos MA; Spätjens RL; Leunissen JD; Carmeliet E; Wellens HJ
    Circulation; 1999 Dec; 100(24):2455-61. PubMed ID: 10595960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel mutation in the transmembrane nonpore region of the KCNH2 gene causes severe clinical manifestations of long QT syndrome.
    Liu L; Hayashi K; Kaneda T; Ino H; Fujino N; Uchiyama K; Konno T; Tsuda T; Kawashiri MA; Ueda K; Higashikata T; Shuai W; Kupershmidt S; Higashida H; Yamagishi M
    Heart Rhythm; 2013 Jan; 10(1):61-7. PubMed ID: 23010577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long QT syndrome-associated mutations in intrauterine fetal death.
    Crotti L; Tester DJ; White WM; Bartos DC; Insolia R; Besana A; Kunic JD; Will ML; Velasco EJ; Bair JJ; Ghidoni A; Cetin I; Van Dyke DL; Wick MJ; Brost B; Delisle BP; Facchinetti F; George AL; Schwartz PJ; Ackerman MJ
    JAMA; 2013 Apr; 309(14):1473-82. PubMed ID: 23571586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital long QT syndrome and 2:1 atrioventricular block: an optimistic outcome in the current era.
    Aziz PF; Tanel RE; Zelster IJ; Pass RH; Wieand TS; Vetter VL; Vogel RL; Shah MJ
    Heart Rhythm; 2010 Jun; 7(6):781-5. PubMed ID: 20197117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-invasive testing of acquired long QT syndrome: evidence for multiple arrhythmogenic substrates.
    Chevalier P; Rodriguez C; Bontemps L; Miquel M; Kirkorian G; Rousson R; Potet F; Schott JJ; Baró I; Touboul P
    Cardiovasc Res; 2001 May; 50(2):386-98. PubMed ID: 11334843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of KCNE1 induces QT interval prolongation in patients with chronic heart failure.
    Watanabe E; Yasui K; Kamiya K; Yamaguchi T; Sakuma I; Honjo H; Ozaki Y; Morimoto S; Hishida H; Kodama I
    Circ J; 2007 Apr; 71(4):471-8. PubMed ID: 17384445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripartum cardiomyopathy presenting with syncope due to Torsades de pointes: a case of long QT syndrome with a novel KCNH2 mutation.
    Nishimoto O; Matsuda M; Nakamoto K; Nishiyama H; Kuraoka K; Taniyama K; Tamura R; Shimizu W; Kawamoto T
    Intern Med; 2012; 51(5):461-4. PubMed ID: 22382559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.